TCM Limited Q1 FY26-27 Results: Revenue Up, Loss Narrows

Revenue growth above 20%Net loss reportedResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹43.00

prior close

—

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.2%-0.2% vs market

Commodity Chemicals peers, median of 54sector+0.1%-0.1% vs sector

On the reaction day the stock moved 0.2 pts less than Nifty Microcap 250 and 0.1 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.0+0.2-0.2+0.1-0.1

Next day

—+0.2—+0.4—

+1.2+0.4+0.8-0.0+1.2

-2.3+0.7-3.1-0.4-1.9

-3.6+0.1-3.7-0.3-3.3

+1.2+0.7+0.5+0.8+0.3

-5.1+1.2-6.3+0.0-5.1

15d

+1.2+0.7+0.4+1.3-0.2

+7.0-1.2+8.2+0.3+6.7

+16.0-1.1+17.2+2.1+13.9

—————

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 54Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

TCM Limited's board approved Q1 FY26-27 results for quarter ended 30 June 2026. Standalone revenue grew about 32 percent YoY to 402.01 lakhs from 304.87 lakhs. Consolidated revenue jumped about 52 percent to 487.97 lakhs from 320.97 lakhs. Despite top-line growth, both reported losses. Consolidated net loss narrowed to 160.13 lakhs from 235.26 lakhs YoY. EPS stood at minus 2.14 versus minus 3.00 YoY. Auditor issued a clean limited review report. 82nd AGM scheduled for 25 September 2026. Two independent directors recommended for reappointment.

Likely market impact

Revenue growth and narrowing losses are encouraging, but bottom line remains negative, signalling continued profitability challenges for shareholders.